Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Harnessing lipid nanoparticles for efficient CRISPR delivery
Jingyue Yan
, Diana D. Kang
,
Yizhou Dong
Research output
:
Contribution to journal
›
Review article
›
peer-review
67
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Harnessing lipid nanoparticles for efficient CRISPR delivery'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lipid Nanoparticles
100%
CRISPR Delivery
100%
In Cancer
66%
DNA Sequencing
33%
Recent Advances
33%
T Cells
33%
Infectious Diseases
33%
Cancer Patients
33%
Phase I Trial
33%
Scissors
33%
Biomedical Research
33%
Potential Therapeutics
33%
Genetic Disease
33%
CRISPR-Cas System
33%
Cas9 Protein
33%
Nanomaterials
33%
Genome Editing
33%
Novel Lipids
33%
Nobel Prize in Chemistry
33%
Cancer Genetics
33%
CRISPR Activation
33%
Flexible Genome
33%
Intracellular Barriers
33%
Extracellular Barriers
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Clinical Trial
100%
Genetic Disorder
100%
Lipid
100%
Solid Lipid Nanoparticle
100%
Nanomaterial
100%
Diseases
100%
Medicine and Dentistry
Clustered Regularly Interspaced Short Palindromic Repeat
100%
Solid Lipid Nanoparticle
100%
Malignant Neoplasm
20%
Clinical Trial
20%
T Cell
20%
Genetic Disorder
20%
DNA Sequence
20%
Ex Vivo
20%
Cas9
20%
Biomedical Research
20%
Infectious Disease
20%
Genome Editing
20%
Nanomaterial
20%
Cancer Genetics
20%
Lipid
20%
CRISPR Cas System
20%
Genetics
20%
Biochemistry, Genetics and Molecular Biology
CRISPR
100%
Lipid Nanoparticles
100%
Genetics
25%
DNA Sequence
25%
Clinical Trial
25%
T Cell
25%
CRISPR Cas System
25%
Genetic Disorder
25%
CRISPR/Cas9
25%
Genome Editing
25%
Cancer Genetics
25%
Lipid
25%
Chemistry
Nanoparticle
100%
Lipid
100%
Chemistry
50%
DNA Sequence
50%
Nanomaterial
50%
Neuroscience
CRISPR
100%
Lipid
100%
Genetics
40%
T Cell
20%
In Vivo
20%
DNA Sequencing
20%
Nanomaterial
20%
CRISPR Cas System
20%